-DOCSTART- -X- O
Background -X- _ O
and -X- _ O
Aims -X- _ O
: -X- _ O
The -X- _ O
risk -X- _ O
of -X- _ O
suffering -X- _ O
from -X- _ O
some -X- _ O
infectious -X- _ O
diseases -X- _ O
can -X- _ O
be -X- _ O
related -X- _ O
to -X- _ O
specific -X- _ O
microbiota -X- _ O
profiles. -X- _ O
Specifically -X- _ O
, -X- _ O
the -X- _ O
nasopharyngeal -X- _ O
microbiota -X- _ O
could -X- _ O
play -X- _ O
a -X- _ O
role -X- _ O
as -X- _ O
a -X- _ O
risk -X- _ O
or -X- _ O
protective -X- _ O
factor -X- _ O
in -X- _ O
the -X- _ O
development -X- _ O
of -X- _ O
invasive -X- _ O
disease -X- _ O
caused -X- _ O
by -X- _ O
S. -X- _ O
pneumoniae. -X- _ O
Methodology -X- _ O
: -X- _ O
We -X- _ O
analyzed -X- _ O
the -X- _ O
nasopharyngeal -X- _ O
microbiota -X- _ O
of -X- _ O
children -X- _ B-Patient
with -X- _ I-Patient
invasive -X- _ I-Patient
pneumococcal -X- _ I-Patient
disease -X- _ I-Patient
( -X- _ I-Patient
IPD -X- _ I-Patient
) -X- _ I-Patient
and -X- _ O
that -X- _ O
of -X- _ O
healthy -X- _ B-Comparison
controls -X- _ I-Comparison
matched -X- _ O
by -X- _ O
age -X- _ O
, -X- _ O
sex -X- _ O
, -X- _ O
and -X- _ O
seasonality -X- _ O
from -X- _ O
Catalonia -X- _ O
, -X- _ O
Spain. -X- _ O
Epidemiological -X- _ O
, -X- _ O
microbiological -X- _ O
and -X- _ O
clinical -X- _ O
variables -X- _ O
were -X- _ O
considered -X- _ O
to -X- _ O
compare -X- _ O
microbiota -X- _ O
profiles -X- _ O
, -X- _ O
analyzed -X- _ O
by -X- _ O
sequencing -X- _ O
the -X- _ O
V1â€“V4 -X- _ O
region -X- _ O
of -X- _ O
the -X- _ O
16S -X- _ O
rRNA -X- _ O
gene. -X- _ O
Results -X- _ O
: -X- _ O
Twenty-eight -X- _ B-Patient
children -X- _ I-Patient
with -X- _ I-Patient
IPD -X- _ I-Patient
( -X- _ O
median -X- _ O
age -X- _ O
43 -X- _ O
months -X- _ O
) -X- _ O
and -X- _ O
28 -X- _ B-Comparison
controls -X- _ I-Comparison
( -X- _ O
42.6 -X- _ O
months -X- _ O
) -X- _ O
were -X- _ O
included -X- _ O
in -X- _ O
the -X- _ O
study. -X- _ O
IPD -X- _ B-Outcome
children -X- _ I-Outcome
presented -X- _ I-Outcome
a -X- _ I-Outcome
significantly -X- _ I-Outcome
higher -X- _ I-Outcome
bacterial -X- _ I-Outcome
diversity -X- _ I-Outcome
and -X- _ I-Outcome
richness -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
< -X- _ I-Outcome
0.001 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Principal -X- _ I-Outcome
coordinate -X- _ I-Outcome
analysis -X- _ I-Outcome
revealed -X- _ I-Outcome
three -X- _ I-Outcome
different -X- _ I-Outcome
microbiota -X- _ I-Outcome
profiles -X- _ I-Outcome
: -X- _ I-Outcome
microbiota -X- _ I-Outcome
A -X- _ I-Outcome
, -X- _ I-Outcome
dominated -X- _ I-Outcome
by -X- _ I-Outcome
the -X- _ I-Outcome
genus -X- _ I-Outcome
Dolosigranulum -X- _ I-Outcome
( -X- _ I-Outcome
44.3 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
; -X- _ I-Outcome
Microbiota -X- _ I-Outcome
B -X- _ I-Outcome
, -X- _ I-Outcome
mostly -X- _ I-Outcome
represented -X- _ I-Outcome
by -X- _ I-Outcome
Streptococcus -X- _ I-Outcome
( -X- _ I-Outcome
36.9 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
Staphylococcus -X- _ I-Outcome
( -X- _ I-Outcome
21.3 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
a -X- _ I-Outcome
high -X- _ I-Outcome
diversity -X- _ I-Outcome
of -X- _ I-Outcome
anaerobic -X- _ I-Outcome
genera -X- _ I-Outcome
including -X- _ I-Outcome
Veillonella -X- _ I-Outcome
, -X- _ I-Outcome
Prevotella -X- _ I-Outcome
and -X- _ I-Outcome
Porphyromonas -X- _ I-Outcome
; -X- _ I-Outcome
and -X- _ I-Outcome
Microbiota -X- _ I-Outcome
C -X- _ I-Outcome
, -X- _ I-Outcome
mainly -X- _ I-Outcome
containing -X- _ I-Outcome
Haemophilus -X- _ I-Outcome
( -X- _ I-Outcome
52.1 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
Moraxella -X- _ I-Outcome
( -X- _ I-Outcome
31.4 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
only -X- _ I-Outcome
explanatory -X- _ I-Outcome
factor -X- _ I-Outcome
for -X- _ I-Outcome
the -X- _ I-Outcome
three -X- _ I-Outcome
microbiotas -X- _ I-Outcome
was -X- _ I-Outcome
the -X- _ I-Outcome
classification -X- _ I-Outcome
of -X- _ I-Outcome
children -X- _ I-Outcome
into -X- _ I-Outcome
disease -X- _ I-Outcome
or -X- _ I-Outcome
healthy -X- _ I-Outcome
controls -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.006 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
A -X- _ I-Outcome
significant -X- _ I-Outcome
negative -X- _ I-Outcome
correlation -X- _ I-Outcome
was -X- _ I-Outcome
found -X- _ I-Outcome
between -X- _ I-Outcome
Dolosigranulum -X- _ I-Outcome
vs. -X- _ I-Outcome
Streptococcus -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.029 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
suggesting -X- _ I-Outcome
a -X- _ I-Outcome
potential -X- _ I-Outcome
antagonistic -X- _ I-Outcome
effect -X- _ I-Outcome
against -X- _ I-Outcome
pneumococcal -X- _ I-Outcome
pathogens. -X- _ I-Outcome
Conclusions -X- _ O
: -X- _ O
The -X- _ O
higher -X- _ B-Outcome
bacterial -X- _ I-Outcome
diversity -X- _ I-Outcome
and -X- _ I-Outcome
richness -X- _ I-Outcome
in -X- _ I-Outcome
children -X- _ I-Outcome
with -X- _ I-Outcome
IPD -X- _ I-Outcome
could -X- _ I-Outcome
suggest -X- _ I-Outcome
an -X- _ I-Outcome
impaired -X- _ I-Outcome
immune -X- _ I-Outcome
response. -X- _ I-Outcome
This -X- _ O
lack -X- _ O
of -X- _ O
immune -X- _ O
competence -X- _ O
could -X- _ O
be -X- _ O
aggravated -X- _ O
by -X- _ O
breastfeeding -X- _ O
< -X- _ O
6 -X- _ O
months -X- _ O
and -X- _ O
by -X- _ O
the -X- _ O
presence -X- _ O
of -X- _ O
keystone -X- _ O
pathogens -X- _ O
such -X- _ O
as -X- _ O
Porphyromonas -X- _ O
, -X- _ O
a -X- _ O
bacterium -X- _ O
which -X- _ O
has -X- _ O
been -X- _ O
shown -X- _ O
to -X- _ O
be -X- _ O
able -X- _ O
to -X- _ O
manipulate -X- _ O
the -X- _ O
immune -X- _ O
response -X- _ O
, -X- _ O
and -X- _ O
that -X- _ O
could -X- _ O
favor -X- _ O
the -X- _ O
overgrowth -X- _ O
of -X- _ O
many -X- _ O
proteolytic -X- _ O
anaerobic -X- _ O
organisms -X- _ O
giving -X- _ O
rise -X- _ O
to -X- _ O
a -X- _ O
dramatic -X- _ O
dysbiosis. -X- _ O
From -X- _ O
an -X- _ O
applied -X- _ O
viewpoint -X- _ O
, -X- _ O
we -X- _ O
found -X- _ O
suggestive -X- _ O
microbiota -X- _ O
profiles -X- _ O
associated -X- _ O
to -X- _ O
IPD -X- _ O
or -X- _ O
asymptomatic -X- _ O
colonization -X- _ O
that -X- _ O
could -X- _ O
be -X- _ O
used -X- _ O
as -X- _ O
disease -X- _ O
biomarkers -X- _ O
or -X- _ O
to -X- _ O
pave -X- _ O
the -X- _ O
way -X- _ O
for -X- _ O
characterizing -X- _ O
health-associated -X- _ O
inhabitants -X- _ O
of -X- _ O
the -X- _ O
respiratory -X- _ O
tract. -X- _ O
The -X- _ O
identification -X- _ O
of -X- _ O
beneficial -X- _ O
bacteria -X- _ O
could -X- _ O
be -X- _ O
useful -X- _ O
to -X- _ O
prevent -X- _ O
pneumococcal -X- _ O
infections -X- _ O
by -X- _ O
integrating -X- _ O
those -X- _ O
microorganisms -X- _ O
in -X- _ O
a -X- _ O
probiotic -X- _ O
formula. -X- _ O
The -X- _ O
present -X- _ O
study -X- _ O
suggests -X- _ O
not -X- _ O
only -X- _ O
respiratory -X- _ O
tract -X- _ O
samples -X- _ O
, -X- _ O
but -X- _ O
also -X- _ O
breast -X- _ O
milk -X- _ O
, -X- _ O
as -X- _ O
a -X- _ O
potential -X- _ O
source -X- _ O
of -X- _ O
those -X- _ O
beneficial -X- _ O
bacteria -X- _ O
. -X- _ O

